Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
668 participants
OBSERVATIONAL
2022-06-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Most outcome parameters are nowadays well known. (e.g., initial rhythm, age, early defibrillation, etc.) Nevertheless, we still do not know today how relevant the corresponding factors actually are, especially in relation to each other. One approach to this might be machine learning methods such as "random forest", which might be able to create a predictive model. However, this has not been attempted to date.
The hypothesis of this work is to find out if it is possible to accurately predict the probability of surviving an in-hospital resuscitation using the machine learning method "random forest" and if particularly relevant outcome parameters can be identified.
Design: retrospective data analysis of all data sets recorded in the resuscitation register of Kepler University Hospital.
Measures and Procedure: Review of the registry for missing data as well as false alarms of the CPR team and, if necessary, exclusion of these data sets; evaluation of the data sets using the machine learning method random forest.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Genetic-molecular Causes of Out-of-Hospital Cardiac Arrest: from Patients to Families
NCT06844851
New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes.
NCT06351956
Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest
NCT00472147
German Cardiac Arrest Registry
NCT05142124
Ventricular Fibrillation Following Out-of-hospital Cardiac Arrest
NCT05325385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outcome CPC Positive
Outcome CPC Positive
CPC
CPC
Outcome CPC Negative
Outcome CPC Negative
CPC
CPC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPC
CPC
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kepler University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Tschoellitsch, MD
Role: PRINCIPAL_INVESTIGATOR
Kepler University Hospital and Johannes Kepler University, Linz, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Hospital
Linz, Upper Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREDIHCA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.